RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yohannes Tesfaigzi to bcl-2 Homologous Antagonist-Killer Protein

Back to Details
This is a "connection" page, showing publications Yohannes Tesfaigzi has written about bcl-2 Homologous Antagonist-Killer Protein.
Yohannes Tesfaigzi
Connection Strength
0.618
bcl-2 Homologous Antagonist-Killer Protein
  1. Mebratu YA, Leyva-Baca I, Wathelet MG, Lacey N, Chand HS, Choi AMK, Tesfaigzi Y. Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria. Nat Commun. 2017 10 06; 8(1):803.
    View in: PubMed
    Score: 0.618
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support